Approval · Notice of Compliance 2137 · 2001
XELODA: Notice of Compliance 2137
Issued April 6, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2137
- Date
- April 6, 2001
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph update
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XELODA | Not yet assigned | — |
Medicinal ingredients
- CAPECITABINE 150 MG per TAB
- CAPECITABINE 500 MG per TAB